The abstract, Phase 1 Dose-Escalation Study of Next-Generation Nectin-4 Targeting Antibody-Drug Conjugate CRB-701 (SYS6002) in US And UK Patients with Urothelial Cancer and other Solid Tumors ( Perez, ...

The bank mobilised deposits of more than Tk5,000 crore in 2024 — the highest in a single year in its recent history, thanks to customer trust even amid a crisis in the banking sector ...

We are thrilled to have Patrick step into this pivotal role,” said Benedikt von Braunmühl, CEO of Rentschler Biopharma. “Patrick’s in-depth understanding of our clients’ needs, coupled with his ...

Economist and former World Bank official Syed Akhtar Mahmood shared his insights with The Business Standard, analysing the challenges of fostering sustainable and inclusive development in Bangladesh ...

Adani, which signed a 25-year contract under former Prime Minister Sheikh Hasina in 2017, has been supplying power from its ...

CEO Tom Polen said BD will “double down on shifting our portfolio, both organically and inorganically through tuck-in M&A, into higher-growth, high-margin accretive growth spaces.” ...

A new BD will have four new operating segments: medical essentials, connected care, BioPharma systems and interventional. Ozempic has been approved to reduce the risk of worsening kidney disease ...

The state-run Bangladesh Power Development Board (BPDB) said it had been paying $85 million a month to Adani to clear outstanding dues and has now told the company to resume supply from the second ...